3AM Stock Chart & Stats
€18.00
-€0.20(-0.67%)
At close: 4:00 PM EST
€18.00
-€0.20(-0.67%)
Day’s Range― - ―
52-Week Range€15.00 - €43.40
Previous CloseN/A
Volume0.00
Average Volume (3M)0.00
Market Cap
€2.13B
Enterprise Value€2.48B
Total Cash (Recent Filing)€478.38M
Total Debt (Recent Filing)€1.07B
Price to Earnings (P/E)79.6
Beta0.30
Next Earnings
Aug 12, 2026EPS Estimate
0.29Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)0.62
Shares Outstanding49,583,420
10 Day Avg. Volume0
30 Day Avg. Volume0
Financial Highlights & Ratios
PEG Ratio-1.09
Price to Book (P/B)1.56
Price to Sales (P/S)0.38
P/FCF Ratio11.65
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
€40.16Price Target Upside123.10% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering9
EPS Forecast (FY)1.12
Revenue Forecast (FY)€3.52B
Bulls Say, Bears Say
Bulls Say
Strong Free Cash Flow GenerationSustained, sizable free cash flow provides durable funding for deleveraging, working-capital needs tied to full-risk conversions, and reinvestment in platform capabilities. Strong FCF reduces dependence on external capital and supports multi-quarter execution of value-based contracts.
Material Improvement In Leverage And Balance SheetLower leverage materially improves financial flexibility to absorb enrollment or regulatory shocks, pursue integration synergies, and invest in care-management tech. A stronger balance sheet makes risk-bearing contract expansion more sustainable over the medium term.
Scalable AI-enabled Platform And High Full-risk PenetrationA platform that automates member interactions and improves clinical gap closure creates durable operating leverage, lowers per-member costs, and strengthens provider stickiness. High and growing full-risk penetration aligns incentives and can sustainably convert scale into margin over time.
Bears Say
Compressed Margins And Low ReturnsMaterial margin compression and weak ROE indicate the business currently converts revenue into little incremental profit. Until gross and net margins recover, capital returns will remain muted and the company may struggle to finance growth internally without stressing profitability.
Enrollment And HQAF Timing UncertaintyVolatility in Medicaid/Exchange enrollment and unresolved HQAF contributions create structural revenue and funding uncertainty across the next several quarters. Conservative planning limits upside and complicates forecasting for value-based contracts that depend on stable member bases.
Full-risk Cohort Maturation And Working-capital StrainExpanding full-risk exposure brings upfront cash strain and lower initial margins as cohorts mature. This structural timing mismatch can depress near-term cash conversion and add volatility to reported results until cohorts reach steady-state economics.
3AM FAQ
What was Astrana Health Inc.’s price range in the past 12 months?
Astrana Health Inc. lowest stock price was €15.00 and its highest was €43.40 in the past 12 months.
What is Astrana Health Inc.’s market cap?
Astrana Health Inc.’s market cap is €2.13B.
When is Astrana Health Inc.’s upcoming earnings report date?
Astrana Health Inc.’s upcoming earnings report date is Aug 12, 2026 which is in 40 days.
How were Astrana Health Inc.’s earnings last quarter?
Astrana Health Inc. released its earnings results on May 07, 2026. The company reported €0.254 earnings per share for the quarter, missing the consensus estimate of €0.261 by -€0.008.
Is Astrana Health Inc. overvalued?
According to Wall Street analysts Astrana Health Inc.’s price is currently Undervalued.
Does Astrana Health Inc. pay dividends?
Astrana Health Inc. does not currently pay dividends.
What is Astrana Health Inc.’s EPS estimate?
Astrana Health Inc.’s EPS estimate is 0.29.
How many shares outstanding does Astrana Health Inc. have?
Astrana Health Inc. has 49,583,420 shares outstanding.
What happened to Astrana Health Inc.’s price movement after its last earnings report?
Astrana Health Inc. reported an EPS of €0.254 in its last earnings report, missing expectations of €0.261. Following the earnings report the stock price went up 1.361%.
Which hedge fund is a major shareholder of Astrana Health Inc.?
Currently, no hedge funds are holding shares in DE:3AM
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Astrana Health Stock Smart Score
Outperform
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Strong Buy
Average Price Target:
€40.16 (123.10% Upside)
€40.16 (123.10% Upside)
Blogger Sentiment
Bullish
DE:3AM Sentiment 70%
Sector Average ―
Sector Average ―
News Sentiment
Very Bullish
Bullish news 100%
Bearish news 0%
Bearish news 0%
Technicals
SMA
Positive
20 days / 200 days
Momentum
98.76%
12-Months-Change
Fundamentals
Return on Equity
3.88%
Trailing 12-Months
Asset Growth
77.19%
Trailing 12-Months
Company Description
Astrana Health Inc.
Astrana Health, Inc., which rebranded from Apollo Medical Holdings, Inc. in February 2024, is a healthcare management firm based in Alhambra, California, founded in 1985. This company delivers medical services throughout the United States, operating with a physician-centered approach powered by advanced technology. Its operations are structured across three distinct divisions: Care Partners, Care Delivery, and Care Enablement. Astrana Health utilizes its exclusive platform for population health management and healthcare delivery to implement an integrated, value-based care model. This strategic approach empowers the healthcare providers within its network to offer high-quality care to their patients. The organization provides extensive care coordination services to a broad spectrum of stakeholders, including patients, their families, primary care physicians, specialists, acute care hospitals, other inpatient facilities, physician groups, and health plans. Its robust physician network encompasses primary care doctors, specialized practitioners, advanced practice providers (extenders), and hospital-based physicians. Astrana Health serves a diverse patient base, primarily those with insurance coverage—such as private plans, Medicare, Medicaid, and HMOs—but also extends care to uninsured individuals.
3AM Company Deck
3AM Earnings Call
Q1 2026
0:00 / 0:00
Earnings Call Sentiment|Positive
The call presented a strong operational and financial quarter with outsized revenue and EBITDA growth, meaningful free cash flow, accelerated deleveraging, confirmed platform‑driven operating leverage from AI, and on‑track integration of the Prospect acquisition. Management remains deliberately conservative in full‑year guidance due to enrollment and HQAF timing uncertainties and highlighted working capital effects from full‑risk transitions. Overall, the positives (robust growth, margin expansion levers, rapid deleveraging, and platform advantages) outweigh the manageable execution and macro/regulatory uncertainties called out by management.View all DE:3AM earnings summaries3AM Stock 12 Month Forecast
All Analysts
Top Analysts
Average Price Target
€40.16
▲(123.10% Upside)
Technical Analysis
1 Day
3 Days
1 Week
1 Month
Healthcare Services
―
Pediatrix Medical Group
―
Select Medical
―
US Physical Therapy
―
Aveanna Healthcare Holdings
―
Options Prices
Currently, No data available
---









